Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis

Abstract

Respiratory syncytial virus (RSV) prophylaxis in high-risk infants is an effective intervention for the prevention of severe disease. The aim of this study was to determine the ideal target preterm population that might benefit from palivizumab prophylaxis by establishing the main risk factors for acute RSV-related infections. Former premature infants born… (More)
DOI: 10.1007/s10096-017-2976-x

Topics

5 Figures and Tables

Cite this paper

@article{etinkaya2017EfficacyOP, title={Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis}, author={Mesut Çetinkaya and Tugce K Oral and S. Karatekin and Burcu Cebeci and Aslan Babayiğit and Yakup Yesil}, journal={European Journal of Clinical Microbiology & Infectious Diseases}, year={2017}, volume={36}, pages={1629-1634} }